Evaluation of oxaliplatin and tigio combination therapy in locally advanced gastric cancer

Table 2 Analysis of short-term efficacy of patients between two groups

Index	Study group (n = 45)		Control group (n = 45)		χ2	P value
	n	%	n	%
CR	11	24.44	9	20.00
PR	25	55.56	17	37.78
SD	6	13.33	12	26.67
PD	3	6.67	7	15.56
ORR (CR + PR)	36	80.00	26	57.78	11.519	0.011
DCR (CR + PR + SD)	42	93.33	38	84.44	4.215	0.016

CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; ORR: Overall response Rate; DCR: Disease control rate.